Adiponectin signaling pathways in liver diseases

69Citations
Citations of this article
93Readers
Mendeley users who have this article in their library.

Abstract

In the liver, adiponectin regulates both glucose and lipid metabolism and exerts an insulin-sensitizing effect. The binding of adiponectin with its specific receptors induces the activation of a proper signaling cascade that becomes altered in liver pathologies. This review describes the different signaling pathways in healthy and diseased hepatocytes, also highlighting the beneficial role of adiponectin in autophagy activation and hepatic regeneration.

Author supplied keywords

Cite

CITATION STYLE

APA

Gamberi, T., Magherini, F., Modesti, A., & Fiaschi, T. (2018, June 1). Adiponectin signaling pathways in liver diseases. Biomedicines. MDPI AG. https://doi.org/10.3390/biomedicines6020052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free